Aptamer Solutions provides bespoke services to the life sciences sector including the development and manufacture of DNA and RNA aptamers.
Aptamer Therapeutics specialises in the development of nucleic acid Aptamer Drug Conjugates (ApDCs) using our automated discovery platform.
Aptasort have combined a biomarker enrichment process with our aptamer isolation protocols yielding a first-in-kind discovery process.
Aptamer Diagnostics is a contract research organisation created to respond to the need for faster, more accurate and more diverse diagnostics.
- April 20, 2018
- April 19, 2018
- April 18, 2018
- April 16, 2018
- April 12, 2018